| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.03 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |